Dashboard
Manage Tickers

CYTO Cytogen Corp.


$ 0.01 (1.42 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.96 $ -2.23 (-0.37 %)
DIA $ 459.11 $ -3.15 (-0.68 %)
SPY $ 659.49 $ -4.53 (-0.68 %)
TLT $ 91.35 $ 0.68 (0.75 %)
GLD $ 399.00 $ 9.06 (2.34 %)
$ 0.6085
-- x --
-- x --
-- - --
$ 0.45 - $ 2.54
178,968
na
na
$ -0.42
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
11/06/2024 12:05:33

altamira-therapeutics-receives-letter-from-nasdaq-qualifications-department-that-it-is-no-longer-in-compliance
Altamira Therapeutics Receives Letter From...
10/04/2024 20:05:24

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (NASDAQ:CYTO) today announced that it received on Sept...

altamira-therapeutics-obtains-extended-iso-13485-quality-management-system-certification-for-bentrio-nasal-spray
Altamira Therapeutics Obtains Extended ISO...
09/27/2024 13:04:11

altamira-therapeutics-h1-2024-eps-211-up-from-2155-yoy
Altamira Therapeutics H1 2024 EPS $(2.11) ...
09/24/2024 12:05:57

Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(2.11) per share. This is a 90.21 percent increase over losse...

altamira-therapeutics-reports-pricing-of-up-to-12m-public-offering-4m-upfront-with-up-to-additional-8m-of-aggregate-gross-proceeds-upon-exercise-of-milestone-linked-warrants
Altamira Therapeutics Reports Pricing Of U...
09/17/2024 21:11:29

The company announced the pricing of a public offering of an aggregate of 5.55 million common shares (or pre-funded warrants in...

altamira-therapeutics-expands-bentrio-license-and-distribution-agreement-with-nuance-pharma-in-east-and-south-east-asia
Altamira Therapeutics Expands Bentrio Lice...
09/16/2024 12:34:52

Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed reque...

altamira-therapeutics-extends-bentrio-distribution-agreement-with-pharma-nordic-to-include-sweden-and-denmark
Altamira Therapeutics Extends Bentrio Dist...
08/23/2024 13:04:14

Successful launch of Bentrio by Pharma Nordic AS in Norway in 2024 Exclusive distribution agreement extended to also include Sw...

why-lumentum-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket
Why Lumentum Shares Are Trading Higher By ...
08/15/2024 10:32:30

altamira-therapeutics-zbtb46-mrna-nanoparticles-show-significant-tumor-growth-reduction-and-long-term-remission-when-combined-with-anti-pd1-therapy
Altamira Therapeutics' Zbtb46 mRNA Nanopar...
08/12/2024 13:04:42

Results Published In Nature Immunology Highlight Potential To Enhance Effectiveness Of Immune Checkpoint Inhibitors

altamira-therapeutics-publishes-preclinical-data-for-treatment-of-abdominal-aortic-aneurysm-with-sod2-mrna-delivered-by-semaphore-nanoparticles
Altamira Therapeutics Publishes Preclinica...
07/19/2024 13:03:05

 Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdomi...

altamira-therapeutics-highlights-review-article-published-on-use-of-betahistine-in-vertigo-management
Altamira Therapeutics Highlights Review Ar...
06/20/2024 13:05:02

altamira-therapeutics-provides-business-update-on-rna-delivery-platform-announces-improvement-in-rna-nanoparticle-stability-pursues-partnering-opportunities-for-am-125-in-vertigo-and-cns-indications-and-switches-financial-reporting-from-swiss-francs-to-us-dollars
Altamira Therapeutics Provides Business Up...
05/28/2024 14:33:53

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 16:31:11

whats-going-on-with-altamira-therapeutics-stock
What's Going On With Altamira Therapeutics...
05/23/2024 16:20:08

Altamira Therapeutics shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial w...

altamira-therapeutics-announces-publication-of-highlights-from-the-nasar-clinical-trial-on-the-social-media-channels-of-allergy
Altamira Therapeutics Announces Publicatio...
05/23/2024 12:55:33

altamira-therapeutics-announces-filing-of-provisional-patent-application-for-oligophore-nanoparticles-with-sirna-targeting-p65-protein-in-treatment-of-cancer-and-inflammation
Altamira Therapeutics Announces Filing Of ...
05/01/2024 13:00:47

altamira-therapeutics-announces-publication-of-results-from-bentrio-trial-in-seasonal-allergic-rhinitis-in-peer-reviewed-journal
Altamira Therapeutics Announces Publicatio...
04/24/2024 12:48:31

Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journalStudy met ...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/22/2024 12:07:03

altamira-therapeutics-fy-eps-1647-sales-28447k-down-from-33037k-yoy
Altamira Therapeutics FY EPS $(16.47) Sale...
04/10/2024 13:21:23

Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(16.47) per share. This is a 97.38 percent increase over loss...

altamira-therapeutics-fy-gaap-eps-chf1480-up-from-chf40960-yoy-other-operating-income-chf25559k-up-from-chf933k-yoy
Altamira Therapeutics FY GAAP EPS CHF(14.8...
04/10/2024 12:06:51

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION